Patents by Inventor Scott J. Dylla

Scott J. Dylla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Light chain variable regions
    Patent number: 11033634
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: June 15, 2021
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-PTK7 antibodies and methods of use
    Patent number: 10836831
    Abstract: Anti-PTK7 modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: November 17, 2020
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Orit Foord, Scott J. Dylla, Robert A. Stull, Alex Bankovich, Alexandra Leida Liana Lazetic, Jeffrey Bernstein
  • ANTI SEZ6 ANTIBODIES AND METHODS OF USE
    Publication number: 20200181256
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 12, 2019
    Publication date: June 11, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL, MICHAEL TORGOV, HUI SHAO, DAVID LIU
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20200138969
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 6, 2019
    Publication date: May 7, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti SEZ6 antibodies and methods of use
    Patent number: 10533051
    Abstract: Provided are novel seizure related 6 (SEZ6) modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: January 14, 2020
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190247510
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 15, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190046656
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • NOVEL ANTI-MMP16 ANTIBODIES AND METHODS OF USE
    Publication number: 20190022242
    Abstract: Provided are novel anti-MMP16 antibodies and antibody drug conjugates, and methods of using such anti-MMP16 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 24, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, SAMUEL A. WILLIAMS, SCOTT J. DYLLA, ZHAO HUANG, LAURA SAUNDERS, DAVID LIU, CASEY FRANKLIN, DAVID COELHO
  • Anti-DLL3 antibody drug conjugates for treating cancer
    Patent number: 10137204
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: November 27, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES
    Publication number: 20180296691
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: January 22, 2018
    Publication date: October 18, 2018
    Applicants: PFIZER, INC., ABBVIE STEMCENTRX LLC
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 10087258
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: October 2, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
    Publication number: 20180243435
    Abstract: Provided are novel anti-DLL3 antibodies and antibody drug conjugates, and methods of using such anti-DLL3 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 30, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SCOTT J. DYLLA, BRIAN SLINGERLAND, TAE HAN, JOHN PEATTIE, HOLGER KARSUNKY, WADE C. ANDERSON
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20180237512
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: April 18, 2018
    Publication date: August 23, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JOHANNES HAMPL, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL
  • Modulators and methods of use
    Patent number: 10017565
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: July 10, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20180162952
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 14, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ORIT FOORD, SCOTT J. DYLLA, ROBERT A. STULL, ALEX BANKOVICH, ALEXANDRA LEIDA LIANA LAZETIC, JEFFREY BERNSTEIN
  • Modulators and methods of use
    Patent number: 9969798
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: May 15, 2018
    Assignee: AbbVie Stemcentrx LLP
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • Identification and enrichment of cell subpopulations
    Patent number: 9945842
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: April 17, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9937268
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: April 10, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-PTK7 ANTIBODY-DRUG CONJUGATES
    Publication number: 20180094075
    Abstract: The present invention provides anti-PTK7 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: September 1, 2017
    Publication date: April 5, 2018
    Applicants: PFIZER INC., ABBVIE STEMCENTRX LLC
    Inventors: Marc Isaac DAMELIN, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Methods of making DLL3 antibody drug conjugates
    Patent number: 9931420
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: April 3, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao